News Merck & Co., Inc.

Equities

MRK

US58933Y1055

Pharmaceuticals

Market Closed - Nyse Other stock markets 01:30:02 09/05/2026 am IST			5-day change	1st Jan Change
111.38 ^USD	-0.82%		-0.70%	+5.81%

07/05	The Rally Spreads
05/05	Merck Completes Terns Pharmaceuticals Acquisition	MT

All News

Mentions Relevance

08/05	Merck : Statement on Daiichi Sankyo Update to Manufacturing and Supply Plan - Merck.com	PU
07/05	Merck Scientists Publish Landmark Paper on Novel Method for Large-Scale Biocatalytic Synthesis of Investigational Oral PCSK9 Inhibitor, Enlicitide Decanoate	BU
05/05	Merck Completes Terns Pharmaceuticals Acquisition	MT
05/05	Merck Completes Acquisition of Terns Pharmaceuticals, Inc.	BU
01/05	Goldman Sachs Adjusts Merck Price Target to $137 From $133	MT
01/05	Wells Fargo Adjusts Merck Price Target to $145 From $150	MT
01/05	Morgan Stanley Raises Price Target on Merck to $112 From $109, Keeps Equalweight Rating	MT
30/04	Merck beats quarterly sales expectations as Keytruda fuels growth	RE
30/04	Merck Q1 adjusted loss per share $1.28 versus IBES estimate $-1.51	RE
30/04	Merck posts quarterly loss due to Cidara charge, sales rise 5%	RE
30/04	Merck & Co., Inc., Q1 2026 Earnings Call, Apr 30, 2026
30/04	Merck 1Q Sales Rise on Continued Keytruda Growth -- Update	DJ
30/04	Merck & Co., Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
30/04	Merck beats quarterly sales expectations as Keytruda fuels growth	RE
30/04	Merck Swings to Q1 Adjusted Loss, Sales Rise; 2026 Outlook Updated; Shares Up Pre-Bell	MT
30/04	Earnings Flash (MRK) Merck & Co., Inc., Rahway, N.J., USA Reports Q1 Revenue $16.29B, vs. FactSet Est of $15.85B	MT
30/04	(MRK) Merck Expects 2026 Sales Range $65.8B - $67.0B, vs. FactSet Est of $66.58B	MT
30/04	Earnings Flash (MRK) Merck & Co., Inc., Rahway, N.J., USA Posts Q1 Adjusted Loss $1.28 per Share, vs. FactSet Est of $-1.47	MT
30/04	(MRK) Merck Expects 2026 Adjusted EPS Range $5.04-$5.16, vs. FactSet Est of $5.10	MT
30/04	Merck : Icon 1Q26 Merck Earnings Announcement	PU
30/04	Merck 1Q Sales Rise on Continued Keytruda Growth	DJ
30/04	Merck : Icon 1Q26 Merck Earnings Presentation	PU
30/04	Merck: Q1 Earnings Snapshot	AQ
30/04	Merck & Co., Inc., Rahway, N.J., USA Announces First-Quarter 2026 Financial Results; Highlights Significant Regulatory Approvals and Clinical Milestones	BU
30/04	Merck & Co., Inc. Updates Earnings Guidance for the Full Year 2026	CI